Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDED CURRENT REPORT - MERA PHARMACEUTICALS INC | mera_8k.htm |
EXHIBIT 16.1
June 24, 2011
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Mera Pharmaceuticals, Inc.
File 333-23460
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K/A of Mera Pharmaceuticals, Inc., and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ Jewett, Schwartz, Wolfe & Associates
Hollywood, Florida
June 14, 2011